Pharmacogenomics: Activating Cancer Drug Discovery

Environmental Health Perspectives - United States
doi 10.1289/ehp.112-1277127
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Environmental Health Perspectives

Related search

Cancer Pharmacogenomics

Pathology
Forensic MedicinePathology
2020English

Opportunities and Challenges of Implementing Pharmacogenomics in Cancer Drug Development

2019English

mTOR Mediated Anti-Cancer Drug Discovery

Drug Discovery Today: Therapeutic Strategies
2009English

Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Implications for Cancer Therapy

Pharmacogenomics and Personalized Medicine
Molecular MedicinePharmacology
2011English

Pharmacogenomics on Gastric Cancer

Cancer Biology and Therapy
Cancer ResearchOncologyMolecular MedicinePharmacology
2004English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

Drug Discovery

Journal of Antivirals & Antiretrovirals
2010English

Pharmacogenomics in Clinical Practice and Drug Development

Nature Biotechnology
Applied MicrobiologyBiotechnologyBiomedical EngineeringMolecular MedicineBioengineering
2012English

‘Big Data’ Approaches for Novel Anti-Cancer Drug Discovery

Expert Opinion on Drug Discovery
Drug Discovery
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy